Skip to content

Contour ERCP Cannula M00530870Recalls & reported problems

Boston Scientific Corporation · ERCP Cannula - Ultra Tapered Tip · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08714729099826), received between Aug 16, 2017 and Jun 14, 2024 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Device Contaminated During Manufacture or Shipping” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 1 reportsMay 2024: 0 reportsJun 2024: 1 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Device Contaminated During Manufacture or Shipping1
  • Device Contamination with Chemical or Other Material1
  • Difficult to Advance1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Insufficient Information1
  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 14, 2024Difficult to Advance; Difficult to Advance

    IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CONTOUR ERCP CANNULA WAS ATTEMPTED TO BE USED DURING A PROCEDURE PERFORMED ON (B)(6) 2024. DURING THE PROCEDURE, THE GUIDEWIRE WAS UNABLE TO CROSS WITH THIS DEVICE. ANOTHER GUIDEWIRE WAS USED WITH THIS DEVICE, BUT THE GUIDEWIRE COULD NOT CROSS AS WELL. THE PROCEDURE WAS COMPLETED WITH ANOTHER DEVICE. THE PATIENT WAS REPORTED TO HAVE AN INJURY. NO FURTHER INFORMATION HAS BEEN OBTAINED DESPITE GOOD-FAITH EFFORTS. ADDITIONAL INFORMATION RECEIVED ON DECEMBER 16, 2024: IT WAS REPORTED THAT THERE WAS NO HARM TO THE PATIENT'S HEALTH.

    Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions

    MAUDE report 19538018 ↗
  • MalfunctionApr 26, 2024Device Contaminated During Manufacture or Shipping; Device Contaminated During Manufacture or Shipping

    IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CONTOUR ERCP CANNULA WAS INTENDED TO BE USED IN A PROCEDURE. THE EXACT PROCEDURE DATE WAS UNKNOWN. DURING PREPARATION, IT WAS POINTED OUT BEFORE OPENING THE PACKAGE THAT A HAIR WAS NOTICED IN BETWEEN THE OUTER PACKAGING AND THE INNER DEVICE POUCH. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. NO FURTHER INFORMATION HAS BEEN OBTAINED DESPITE GOOD FAITH EFFORTS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19198049 ↗
  • MalfunctionAug 16, 2017Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material

    IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A CONTOUR ERCP CANNULA WAS USED IN THE DISTAL BILE DUCT DURING AN EXPANDABLE METALLIC STENT (EMS) PROCEDURE PERFORMED ON (B)(6) 2017. ACCORDING TO THE COMPLAINANT, DURING PROCEDURE, A CONTOUR ERCP CANNULA AND A JAGWIRE WAS INSERTED INTO THE PANCREATIC DUCT. AFTER PLACING THE JAGWIRE, THE CANNULA WAS REMOVED FROM THE PATIENT. WHEN THE CANNULA WAS REINSERTED TO PERFORM BILE DUCT CANNULATION, IT WAS NOTICED ON THE MONITOR THAT A FRAGMENT OF THE JAGWIRE COATING WAS INSIDE THE TIP OF THE CANNULA. THE CANNULA WAS REMOVED FROM THE PATIENT AND FLUSHING WAS PERFORMED; THE JAGWIRE FRAGMENT CAME OFF. THE BILE DUCT CANNULATION WAS COMPLETED WITH THIS DEVICE AND A NON-BSC GUIDEWIRE. REPORTEDLY, THERE WAS NO RESISTANCE ENCOUNTERED WHILE MOVING THE GUIDEWIRE WITHIN THE ERCP CANNULA. HOWEVER, A BURR (ROUGH AREA) WAS NOTED AT THE TIP OF THE ERCP CANNULA, AND IT WAS THOUGHT THAT THIS MIGHT HAVE DAMAGED THE GUIDEWIRE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. THE PATIENT'S CONDITION AT THE CONCLUSION OF THE PROCEDURE WAS REPORTED TO BE "GOOD". THIS EVENT HAS BEEN DEEMED A REPORTABLE EVENT BASED ON THE INVESTIGATION RE

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 6798635 ↗

Other Endoscopic retrograde cholangiopancreatography (ERCP) cannula devices

All Endoscopic retrograde cholangiopancreatography (ERCP) cannula devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page